INMD Inmode Ltd

  1. Stocks
  2. Healthcare
  3. NASDAQ: INMD

Price (delayed)

$14.19

Market cap

$835.83M

P/E Ratio

11.35

Dividend/share

N/A

EPS

$1.25

Enterprise value

$444.11M

?
Relative Growth: Rel. Growth: 27
Relative Strength: Rel. Strength: 51
Relative Valuation: Rel. Valuation: 78
Relative Profitability: Rel. Profitability: 72

InMode Ltd. is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radio-frequency (RF) technology. InMode strives to enable new emerging surgical procedures ...

Highlights
The company's debt fell by 27% YoY and by 8% QoQ
The price to earnings (P/E) is 20% more than the last 4 quarters average of 9.6 but 18% less than the 5-year quarterly average of 14.1
INMD's net income has dropped by 57% year-on-year and by 11% since the previous quarter
The EPS is down by 50% year-on-year and by 9% since the previous quarter
Sector: Healthcare
Industry: Medical Devices
Website: http://www.inmodemd.com
Peers: OBIO OM

Key stats

What are the main financial stats of INMD

INMD stock price

How has the Inmode stock price performed over time
Intraday
-1.8%
1 week
-2.67%
1 month
-5.78%
1 year
-5.02%
YTD
-3.4%
QTD
-2.94%

Financial performance

How have Inmode's revenue and profit performed over time
Revenue
$374.63M
Gross profit
$286.68M
Operating income
$69.2M
Net income
$77.51M
Gross margin
76.5%
Net margin
20.7%
INMD's net income has dropped by 57% year-on-year and by 11% since the previous quarter
The company's net margin has shrunk by 53% YoY and by 11% QoQ
Inmode's operating income has decreased by 40% YoY and by 13% QoQ
Inmode's operating margin has decreased by 35% YoY and by 13% from the previous quarter

Price vs fundamentals

How does INMD's price correlate with its fundamentals

Growth

What is Inmode's growth rate over time

Valuation

What is Inmode stock price valuation
INMD P/E details
P/E
11.35
P/B
1.43
P/S
2.23
EV/EBIT
4.88
EV/EBITDA
4.85
EV/Sales
1.19
The EPS is down by 50% year-on-year and by 9% since the previous quarter
The price to earnings (P/E) is 20% more than the last 4 quarters average of 9.6 but 18% less than the 5-year quarterly average of 14.1
INMD's P/B is 65% below its 5-year quarterly average of 4.2 but 4.3% above its last 4 quarters average of 1.4
Inmode's equity has decreased by 4.9% QoQ
INMD's price to sales (P/S) is 59% lower than its 5-year quarterly average of 5.6 and 5% lower than its last 4 quarters average of 2.4
INMD's revenue is down by 7% year-on-year

Efficiency

How efficient is Inmode business performance
Inmode's ROA has plunged by 56% YoY and by 12% from the previous quarter
INMD's return on equity has dropped by 56% year-on-year and by 11% since the previous quarter
The ROS is down by 32% year-on-year and by 11% since the previous quarter
The return on invested capital has declined by 2.9% year-on-year

Dividends

What is INMD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for INMD.

Financial health

How did Inmode financials performed over time
The quick ratio has contracted by 16% YoY and by 8% from the previous quarter
The company's current ratio fell by 15% YoY and by 7% QoQ
The company's debt is 99% lower than its equity
The company's debt fell by 27% YoY and by 8% QoQ
Inmode's equity has decreased by 4.9% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.